SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 348.21 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | -106.65 |
| Book Value / Share | -1.11 |
| Price / Book | n/a |
| NCAV ($M) | -114.10 |
| NCAV / Share | -1.19 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.47 |
| Return on Assets (ROA) | -4.67 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.92 |
| Current Ratio | 0.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 111.51 |
| Assets | 118.97 |
| Liabilities | 225.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 14.72 |
| Operating Income | -97.56 |
| Net Income | -184.21 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -85.93 |
| Cash from Investing | 8.74 |
| Cash from Financing | 145.59 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| IPSEF – Ipsen S.A. | ISCO – International Stem Cell Corporation |
| IVBT – Innovation1 Biotech Inc. | KANT – Kineta, Inc. |
| KAYS – Kaya Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io